Experimental Diet Pill Tricks Body into Thinking It Ate

Below:

Next story in Science

A new drug could trick the body into thinking it had a meal,
according to a new study in mice.

Although the drug is far from becoming a miracle diet pill for
treating obesity in people, it does show promise as a weight-loss
solution, at least in mice, the researchers said. The drug works
in the intestines and mimics the physiological processes that
occur after an animal consumes a meal.

As a result, mice that consume the drug burn calories to make
room for the imaginary calories they didn't actually consume,
according to the study, published today (Jan. 5) in the journal
Nature Medicine.

"It sends out the same signals that normally happen when you eat
a lot of food, so the body starts clearing out space to store
it," said Ronald Evans, director of the Gene Expression
Laboratory at the Salk Institute for Biological Studies in La
Jolla, California.

The drug, called fexaramine, activates a molecular switch that
releases bile acids into the intestines in response to food.
Normally, the job of bile is to help the body digest the food,
but its release also has ripple effects, triggering a set of
other processes throughout the body, Evans said. [ The
7 Biggest Diet Myths ]

The new drug also appears to have fewer side effects than other
similar weight-loss medications because it stays in the
intestines, rather than entering the bloodstream and affecting
the whole body, according to the study.

In the experiments, the researchers gave mice that were on a
high-fat diet and were already obese a daily oral dose of
fexaramine for five weeks. The found that the animals stopped
gaining weight. The drug also lowered the animals' blood sugar
levels and cholesterol levels, and caused a buildup of brown fat,
which helps burn energy. Untreated obese mice in the study
didn't show these improvements.

The drug works by switching on a receptor called the farnesoid X
receptor (FXR), which Evans and his colleagues have studied for
about two decades. Some of the researchers stand to gain
financially if a drug based on the research ever comes to
fruition, the study noted.

After a meal is consumed, FXR triggers the release of bile acids,
and also changes blood sugar levels and causes the body to burn
some fats, the researchers noted.

The researchers said they believe a drug working on the same
principles could one day offer people a nonsurgical treatment for
extreme obesity. Currently, people who are severely obese even
after trying to lose weight though diet and exercise have only a
few treatment options, including gastric
bypass surgery.

But first, the drug has to be tested in bigger animals, such as
primates, and then in humans, before being used as a treatment
for obesity. This process could take a couple of years, the
researchers said.